Science & Technology
Precision MRI with Protein Contrast Agent for Noninvasive Detection of Lung Fibrosis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R42HL170898-02
Award Ceiling
$1.0M
Award Floor
$1.0M
Close Date
Aug 31, 2027
534 days leftTotal Funding
$1.0M
Expected Awards
1
Posted Date
Sep 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2R42HL170898-02
Description
STTR Phase Phase II award: "Precision MRI with Protein Contrast Agent for Noninvasive Detection of Lung Fibrosis" awarded to INLIGHTA BIOSCIENCES L.L.C. in MARIETTA, Georgia. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,026,874. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.